Atrium acquires Nutri-Health Supplements, an innovative and fast-growing U.S. enterprise located in Arizona

    This latest acquisition will allow Atrium to expand its brand portfolio
    with specialized probiotic niche products

    QUEBEC CITY, Jan. 5 /CNW Telbec/ - Atrium Innovations Inc. (TSX: ATB) is
pleased to announce the acquisition of Nutri-Health Supplements, LLC ("NHS"),
a fast-growing enterprise located in Cottonwood, Arizona, U.S. This
acquisition is in line with Atrium's business development strategy since NHS
markets, via multi-channel distribution, specialty niche products endorsed by
health professionals.
    NHS owns proprietary Multi-Probiotic(R) blends which include 16 powerful
probiotic strains that are matrix encapsulated to survive stomach acid and
deliver a high concentration of active cell cultures per capsule. During the
last few years, NHS has experienced impressive growth and achieved
approximately US$27 million in sales for 2008.
    Probiotics is currently one of the fastest-growing specialized niches in
the food supplement market and have become an important part of nutrition.
Human body microbial populations have been altered by the use of substances
that are designed to kill germs and disease. By introducing friendly microbes
into natural gut flora, the resident micro flora will be strengthened.
    The company's brand umbrella includes the Nutri-Health(R) brand which
represents about 90% of NHS' total sales. This brand is sold through the
direct-to-consumer (DTC) channel largely via a well established mail order
program. Furthermore, NHS caters to the health food store and health care
practitioner markets with a portfolio of high potential brands - Sedona
Labs(R), Meta Foods(R), and Sedona Labs Pro(R).
    Atrium has acquired NHS for a first consideration of US$23.9 million
fully paid in cash at the closing of the transaction. Two additional earn-out
payments have been structured based on NHS' 2009 and 2010 EBITDA growth.
    "We are very pleased to acquire Nutri-Health Supplements, an innovative
and successful enterprise that is distinguished by a true culture of
performance. Nutri-Health has built a loyal and rapidly growing clientele over
the years by developing and marketing high quality, health
professional-endorsed, specialized products. Buying Nutri-Health marks our
first acquisition into the DTC segment with a company aligned with our values
and objectives. NHS allows us to acquire complementary expertise in this
market segment in which we had a limited business presence until now. This
opens the door to promising, synergistic development opportunities within
Atrium," said Mr. Pierre Fitzgibbon, President and Chief Executive Officer of

    Conference Call on the Acquisition

    Atrium will hold a conference call and webcast to discuss the NHS
acquisition on January 5, 2009 at 4:30 p.m Eastern Standard Time. Participants
may access the call using the following numbers: 416-644-3420, 514-807-8791 or
800-733-7571. The live webcast will be available via the Company's website at found in the "Investors" section. A replay of the webcast
will also be available on our website for a period of 30 days.

    About NHS

    Nutri-Health Supplements, LLC is a leading developer, manufacturer and
marketer of probiotic and enzymes products. Its premium line of nutraceuticals
primarily consists of proprietary Multi-Probiotic(R) blends and enzyme
formulations designed to address the specific health needs of consumers,
predominantly digestive and immune health. The company primarily markets its
products direct-to-consumer through direct mailing but also distributes other
brands through specialized retail outlets and healthcare practitioners.

    About Atrium

    Atrium Innovations Inc. is a recognized leading developer, manufacturer
and marketer of science-based and professionally endorsed products for the
health and nutrition industries. The Company focuses primarily on growing
segments of the health and nutrition markets which are benefiting from the
trends towards healthy living and the ageing of the population. Atrium markets
a broad portfolio of finished products through its highly specialized sales
and marketing network in more than 35 countries, primarily in North America
and Europe. Atrium has over 780 employees and operates seven manufacturing
facilities. Additional information about Atrium is available on its website at

    Cautionary Note and Forward-Looking Statements

    This press release contains certain forward-looking statements with
respect to the Company. These forward-looking statements, by their nature,
necessarily involve risks and uncertainties that could cause actual results to
differ materially from those contemplated by these forward-looking statements.
The Company considers the assumptions on which these forward-looking
statements are based to be reasonable, but cautions the reader that these
assumptions regarding future events, many of which are beyond its control, may
ultimately prove to be incorrect since they are subject to risks and
uncertainties that affect the Company. For additional information with respect
to these and other factors, see the Company's quarterly and annual filings
with the Canadian securities commissions. The Company disclaims any intention
or obligation to update or revise any forward-looking statements, whether as a
result of new information, future events or otherwise, other than as required
by law.

For further information:

For further information: Investor Relations: Mario Paradis,
Vice-President and Chief Financial Officer, (418) 652-1116,; Media Relations: Frédéric Tremblay, HKDP, (514)
395-0375, ext. 234,

Organization Profile

Atrium Innovations Inc.

More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890